Lara Meisner is CLO & Secretary at Viridian Therapeutics, Inc.\DE (VRDN). They have made 6 open-market trades across 1 company since 2022, most recently 2025-09-29.
CIK 0001883986
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCAX | SELL · 10b5-1 | 2025-09-29 | 2025-10-01 | $14.75 | $997K | +11.2% | -2.3% | -3.1% |
| BCAX | SELL · 10b5-1 | 2025-09-15 | 2025-09-17 | $11.49 | $364K | +26.0% | +65.8% | +64.9% |
| BCAX | SELL · 10b5-1 | 2025-06-16 | 2025-06-18 | $10.43 | $330K | -0.9% | +14.5% | +17.8% |
| BCAX | SELL · 10b5-1 | 2025-03-14 | 2025-03-18 | $12.90 | $2.0M | +8.9% | -1.2% | -18.8% |
| VRDN | SELL | 2023-06-15 | 2023-06-20 | $28.02 | $128K | -4.7% | -17.9% | -30.8% |
| VRDN | SELL · 10b5-1 | 2023-06-02 | 2023-06-06 | $24.90 | $314K | +8.5% | -6.8% | -22.6% |
| VRDN | SELL | 2023-03-09 | 2023-03-10 | $29.07 | $1.7M | -8.0% | -12.2% | -9.3% |
| VRDN | SELL | 2023-01-23 | 2023-01-25 | $35.66 | $488K | -4.9% | -12.6% | -25.0% |
| VRDN | SELL | 2022-12-20 | 2022-12-22 | $29.17 | $970K | -7.1% | +20.5% | -12.6% |
| VRDN | SELL · 10b5-1 | 2022-12-15 | 2022-12-19 | $28.37 | $45K | +5.7% | +33.2% | +1.5% |
| VRDN | SELL | 2022-12-12 | 2022-12-14 | $28.12 | $897K | +3.8% | +31.4% | +3.4% |
| VRDN | SELL | 2022-11-15 | 2022-11-16 | $22.05 | $358K | -0.2% | +21.6% | +43.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.